CU6 4.46% $6.21 clarity pharmaceuticals ltd

Ann: First patient treated in theranostic prostate cancer trial, page-8

  1. 464 Posts.
    lightbulb Created with Sketch. 93
    If TLX gets approval on 23rd September this will go to approx $700m market cap
 
watchlist Created with Sketch. Add CU6 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.